Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
J Infect Dis. 2024 May 8;229(Supplement_3):S316-S321. doi: 10.1093/infdis/jiad453.
Despite remarkable therapeutic advances, hepatitis C virus (HCV) infection continues to be a major global problem. While the development of highly effective direct-acting antivirals has ensured that almost all those who are treated achieve viral cure, progress toward HCV elimination globally has stalled due to challenges upstream of treatment in the cascade of care, namely diagnosis and linkage to care. The major challenge continues to be the relative complexity of HCV diagnosis with the current requirement for a confirmatory HCV RNA test after an initial antibody-positive result. In this review, challenges with the current paradigm are highlighted with a focus on new technologies, as well as simple strategies using existing tools, which may simplify diagnosis and improve linkage to care and treatment. To achieve HCV elimination, improvements in the HCV diagnostics field to allow for a simple single-step diagnosis are required.
尽管在治疗方面取得了显著进展,但丙型肝炎病毒(HCV)感染仍然是一个全球性的主要问题。虽然高效直接作用抗病毒药物的发展确保了几乎所有接受治疗的患者都能实现病毒治愈,但由于治疗前在护理级联中的诊断和链接到护理方面的挑战,全球在消除 HCV 方面的进展已经停滞不前。主要挑战仍然是 HCV 诊断的相对复杂性,目前需要在最初的抗体阳性结果后进行确认性 HCV RNA 检测。在这篇综述中,重点介绍了当前范例存在的挑战,并关注了新技术以及使用现有工具的简单策略,这些策略可能会简化诊断并改善链接到护理和治疗。为了实现 HCV 的消除,需要改进 HCV 诊断领域,以实现简单的一步诊断。